미용의학 시장 - 산업 규모, 점유율, 동향, 기회 및 예측 : 시술 유형별, 지역별 경쟁(2021-2031년)

The Global Aesthetic Medicine Market is projected to expand significantly, from USD 134.02 billion in 2025 to USD 277.25 billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 12.88%. This market covers a wide array of surgical and nonsurgical procedures aimed at improving physical appearance and addressing imperfections. Its widespread growth is primarily driven by an aging global population seeking rejuvenation, increased disposable incomes making elective treatments more accessible, and the rising social acceptance of cosmetic interventions. These combined elements have transformed aesthetic enhancements from exclusive luxuries into standard grooming practices for a diverse population. In 2024, the International Society of Aesthetic Plastic Surgery reported that plastic surgeons globally performed over 17.4 million surgical and 20.5 million nonsurgical procedures.

Market Driver

The primary driver of market expansion is the escalating demand for non-invasive and minimally invasive aesthetic procedures, with consumers increasingly preferring treatments that offer subtle enhancements and shorter recovery periods. This shift has moved the industry's focus from surgical interventions to 'tweakments' like neurotoxins and dermal fillers, a trend notably reflected in younger demographics' growing preference for preventative anti-aging measures, compelling clinics to adjust their service portfolios. The American Academy of Facial Plastic and Reconstructive Surgery's '2024 Annual Trends Survey' from February 2025 indicated that minimally invasive procedures accounted for 80% of all procedures performed by facial plastic surgeons in 2024, highlighting the prevalence of nonsurgical options. Concurrently, ongoing technological advancements in energy-based devices and injectables are boosting market value by improving treatment efficacy and patient safety. Innovations in biostimulators and next-generation neuromodulators are broadening the scope of treatable conditions, enabling practitioners to deliver more natural and longer-lasting results. These breakthroughs not only retain existing patients but also attract new consumer segments seeking reliable aesthetic solutions. Galderma's 'Full Year 2024 Financial Results' (February 2025) reported net sales of $2.299 billion for its Injectable Aesthetics unit, a 9.6% year-on-year increase at constant currency, while Evolus achieved a record total net revenue of $266.3 million in full year 2024, marking 32% growth, further demonstrating the sector's dynamism.

Market Challenge

A significant challenge hindering the rapid expansion of the Global Aesthetic Medicine Market is the stringent regulatory environment for medical devices and procedures. Manufacturers of aesthetic products, including dermal fillers, implants, and laser systems, must navigate intricate approval processes imposed by health authorities like the FDA and EMA. These bodies categorize aesthetic innovations with critical medical devices, demanding extensive and expensive clinical trials to prove safety and efficacy. Such rigorous oversight substantially increases the capital needed for product development and postpones the market entry of advanced technologies. As a result, the high cost of compliance acts as a barrier for smaller innovators and startups, stifling competition and slowing the introduction of new treatments to consumers. This regulatory bottleneck restricts product diversification and impedes the market's agility in addressing evolving patient needs. While the vast number of treatments requiring oversight, such as the over 28.5 million minimally invasive cosmetic procedures performed in 2024 according to the American Society of Plastic Surgeons, necessitates strict vigilance, these uncompromising standards, though essential for public safety, inevitably decelerate the market's overall growth and adaptability.

Market Trends

A significant market trend is the rise of post-weight loss facial rejuvenation solutions, largely spurred by the extensive use of GLP-1 receptor agonists. The rapid weight reduction these medications induce often results in considerable facial volume loss and skin laxity, colloquially known as "Ozempic Face," which demands corrective procedures beyond typical anti-aging treatments. Clinics are increasingly seeing patients who need structural restoration to address these morphological changes, rather than just surface-level enhancements. The American Academy of Facial Plastic and Reconstructive Surgery's '2024 Annual Trends Survey' from February 2025 reported a 50 percent increase in fat grafting procedures performed by facial plastic surgeons in the past year, attributing this surge to patients correcting volume deficits from medication-induced weight loss. Simultaneously, the incorporation of artificial intelligence and augmented reality for personalized diagnostics is transforming patient interaction. Providers are implementing advanced algorithms that analyze skin conditions in real-time, enabling data-driven recommendations that boost consumer confidence. This technology extends beyond simple virtual try-ons to provide profound clinical insights, effectively connecting at-home care with professional aesthetic services. L'Oreal's '2024 Annual Report' (February 2025) highlighted this trend, noting over 110 million uses of its Beauty Tech services across 66 countries, confirming robust demand for AI-powered diagnostic tools in aesthetic care.

Key Market Players

• Evolus, Inc.
• Cynosure LLC.
• Revance Therapeutics, Inc.
• Galderma S.A.
• Alma Lasers Inc.
• AbbVie Inc.
• Solta Medical Inc.
• Lumenis Inc.
• Syneron Inc.
• Bausch Health Companies, Inc.

Report Scope

In this report, the Global Aesthetic Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Aesthetic Medicine Market, By Procedure Type

• Invasive procedures
• Non-invasive procedure

Aesthetic Medicine Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aesthetic Medicine Market.

Available Customizations:

Global Aesthetic Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Aesthetic Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure Type (Invasive procedures {Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, Others }), Non-invasive procedure { Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Others }
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Aesthetic Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Aesthetic Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure Type
  • 6.3.2. Canada Aesthetic Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure Type
  • 6.3.3. Mexico Aesthetic Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure Type

7. Europe Aesthetic Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Aesthetic Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure Type
  • 7.3.2. France Aesthetic Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure Type
  • 7.3.3. United Kingdom Aesthetic Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure Type
  • 7.3.4. Italy Aesthetic Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure Type
  • 7.3.5. Spain Aesthetic Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure Type

8. Asia Pacific Aesthetic Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Aesthetic Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure Type
  • 8.3.2. India Aesthetic Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure Type
  • 8.3.3. Japan Aesthetic Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure Type
  • 8.3.4. South Korea Aesthetic Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure Type
  • 8.3.5. Australia Aesthetic Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure Type

9. Middle East & Africa Aesthetic Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure Type
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Aesthetic Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure Type
  • 9.3.2. UAE Aesthetic Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure Type
  • 9.3.3. South Africa Aesthetic Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure Type

10. South America Aesthetic Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure Type
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Aesthetic Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure Type
  • 10.3.2. Colombia Aesthetic Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure Type
  • 10.3.3. Argentina Aesthetic Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Aesthetic Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Evolus, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cynosure LLC.
• 15.3. Revance Therapeutics, Inc.
• 15.4. Galderma S.A.
• 15.5. Alma Lasers Inc.
• 15.6. AbbVie Inc.
• 15.7. Solta Medical Inc.
• 15.8. Lumenis Inc.
• 15.9. Syneron Inc.
• 15.10. Bausch Health Companies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer